Fig. 2From: The myeloid sarcoma treated by Venetoclax with hypomethylating agent followed by stem cell transplantation: rare case reportDynamics of tumor by FDG-PET/CT. a Study at the onset of the disease; b study after course of induction therapy; c study after course of consolidation therapy; d study after course of specific therapy with Venetoclax and 5-azacitidineBack to article page